Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

After Pfizer's vaccine data, analysts say COVID19 drugmakers face questions about long-term sales prospects
Fierce Pharma
Mon, 11/9/20 - 08:51 pm
Tags:
Pfizer, BioNTech, Gilead Sciences, Eli Lilly, Regeneron, COVID-19, pharma stocks, vaccines, clinical trials
Pfizer Soars as Vaccine Prevents 90% of Covid Cases in Study
Bloomberg
Mon, 11/9/20 - 12:10 pm
Tags:
Pfizer, BioNTech, vaccines, COVID-19, clinical trials
Ionis and Akcea announce that Pfizer initiated clinical study of vupanorsen
Pharmaceutical Business Review
Wed, 11/4/20 - 10:13 am
Tags:
Ionis Pharmaceuticals, Akcea Therapeutics, Pfizer, clinical trials, vupanorsen, cholesterol
Eliquis partners BMS and Pfizer join the pharma crowd urging doctor visits during COVID-19
Fierce Pharma
Mon, 11/2/20 - 10:29 am
Tags:
Pfizer, Bristol-Myers Squibb, Eliquis, DTC advertising, pandemic, COVID-19
Date Is Set for Merger Between Mylan and Pfizer's Upjohn Unit
Motley Fool
Sun, 11/1/20 - 01:33 pm
Tags:
M&A, FTC, Pfizer, Upjohn, Mylan, generics
Pfizer Spinoff Cerevel Therapeutics Begins Trading on the Nasdaq
BioSpace
Wed, 10/28/20 - 11:09 pm
Tags:
Pfizer, Cerevel Therapeutics, SPAC, Arya Sciences, NASDAQ
How Pfizer Missed an Opportunity With Its Q3 Results
Motley Fool
Tue, 10/27/20 - 11:26 pm
Tags:
Pfizer, earnings
Pfizer Q3 cull sees midstage fast-tracked NASH drug axed, with a cancer vaccine and arthritis asset also chopped
Fierce Pharma
Tue, 10/27/20 - 10:44 am
Tags:
Pfizer, earnings, NASH, arthritis, cancer vaccines
No news on Pfizer’s Covid-19 vaccine is good news — and bad news
Stat
Tue, 10/27/20 - 10:35 am
Tags:
Pfizer, vaccines, COVID-19, clinical trials
[video+transcript]What Are the Differences Between the Leading Coronavirus Vaccine Candidates?
Motley Fool
Sun, 10/25/20 - 11:24 pm
Tags:
vaccines, COVID-19, Pfizer, BioNTech, Moderna Therapeutics, JNJ, AstraZeneca
[video + transcript]What's the Timeline for FDA Emergency Use Authorization of Coronavirus Vaccines?
Motley Fool
Sat, 10/24/20 - 11:31 pm
Tags:
FDA, Pfizer, BioNTech, vaccines, COVID-19, Emergency Use Authorization
At key meeting, FDA advisors debate if early coronavirus vaccine approvals may compromise trials
BioPharma Dive
Fri, 10/23/20 - 10:56 am
Tags:
Pfizer, Moderna Therapeutics, vaccines, FDA, COVID-19
IBM and Pfizer Believe Machine Learning Can Predict Alzheimer’s Risk
BioSpace
Thu, 10/22/20 - 11:21 pm
Tags:
Pfizer, IBM, artificial intelligence, machine learning, diagnostics, Alzheimer's disease
Pfizer, Moderna COVID-19 vaccines could reach all Americans by June—if politics don't get in the way: Slaoui
Fierce Pharma
Thu, 10/22/20 - 11:10 am
Tags:
Pfizer, Moderna Therapeutics, Moncef Slaoui, vaccines, COVID-19, Operation Warp Speed
Planes, trucks and ultracold boxes: Pfizer preps massive COVID-19 vaccine distribution effort
Fierce Pharma
Thu, 10/22/20 - 10:45 am
Tags:
Pfizer, vaccines, pandemic, COVID-19, logistics, distribution
Pfizer could haul in $3.5B in 2021 from COVID-19 vaccine: analyst
Fierce Pharma
Wed, 10/21/20 - 11:40 pm
Tags:
Pfizer, profit, vaccines, COVID-19
COVID-19 vaccine biotech Vaccitech nabs Pfizer, Kite vet as full-time CMO
Fierce Biotech
Tue, 10/20/20 - 10:42 am
Tags:
Vaccitech, Pfizer, Kite Pharma, vaccines, AstraZeneca
Merck's rival to Pfizer's Prevnar 13 hits goal in phase 3 again
Fierce Biotech
Tue, 10/20/20 - 10:38 am
Tags:
Merck, Pfizer, vaccines, Prevnar 13, clinical trials, V114, pneumococcal disease
Pfizer: Expanding North Carolina Gene Therapy Facility and Adding Jobs
BioSpace
Mon, 10/19/20 - 11:24 pm
Tags:
Pfizer, North Carolina, gene therapy, hirings, drug manufacturing
Pfizer CEO Anticipates EUA for COVID-19 Vaccine in Late November
BioSpace
Mon, 10/19/20 - 10:59 am
Tags:
Pfizer, Albert Bourla, Emergency Use Authorization, BioNTech, vaccines, COVID-19, clinical trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.